|
|
Logistic Regression Analysis of Factors Affecting the Therapeutic Effect of Immunotherapy For Aplastic Anemia |
Feng Anchao |
Zhumadian First People's Hospital, Zhumadian 463000, China |
|
|
Abstract Objective To investigate the therapeutic effect and influencing factors of immunotherapy for aplastic anemia(AA). Methods 70 AA patients treated were selected.All patients were treated with immunotherapy(cyclosporine + antithymocyte globulin)for 6 months.The treatment effect was evaluated and recorded according to relevant standards,and divided into effective group and ineffective group;Design a general data questionnaire,ask and record the general data and laboratory related indicators of patients,and analyze the influencing factors of immunotherapy in AA patients. Results After 6 months of immunotherapy in 70 AA patients,45 cases were evaluated as effective,and the effective rate was 64.29%(45 / 70);25 cases were evaluated as ineffective,and the ineffective rate was 35.71%(25 / 70);Before treatment,the absolute value of neutrophils(ANC)and reticulocyte count(RET)in the ineffective group were lower than those in the effective group,and the hematopoietic area of bone marrow was smaller than that in the ineffective group(P<0.05);Logistic regression analysis showed that high levels of RET and ANC and large hematopoietic area of bone marrow were the protective factors for the ineffective treatment of AA immunotherapy(or<1,P<0.05). Conclusion High levels of ANC and RET and large hematopoietic area of bone marrow are the protective factors for the therapeutic effect of AA immunotherapy.
|
Received: 28 August 2021
|
|
|
|
|
[1] 刘苏,林少汾,陈启慧,等.128例再生障碍性贫血患儿接受兔源抗胸腺细胞球蛋白联合环孢素治疗的疗效分析[J].国际输血及血液学杂志,2019,42(1):9-17. [2] 陈苗,吴亚妹,周道斌,等.强化免疫抑制治疗和单倍体移植治疗年轻重型再生障碍性贫血的比较[J].基础医学与临床,2020,40(6):759-764. [3] 朱志超,白煜,卢绪章,等.PARP抑制剂olaparib对急性髓系白血病细胞HL-60抑制作用研究[J].实用肿瘤学杂志,2019,33(6):481-485. [4] 付蓉. 再生障碍性贫血诊断与治疗中国专家共识(2017年版)[J].中华血液学杂志,2017,38(1):1-5. [5] Li X,Shi J,Ge M,et al.Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia:a single-center experience[J].PLoS One,2013,8(3):e56648. [6] 袁长威,熊媛媛,张青兰,等.标准免疫抑制治疗联合重组人血小板生成素及艾曲波帕治疗重型再生障碍性贫血2例报告及文献复习[J].临床血液学杂志,2020,33(7):503-507. [7] 柴星星,何广胜,何耀,等.艾曲波帕联合标准剂量强化免疫抑制治疗老年重型再生障碍性贫血[J].临床血液学杂志,2019,32(9):683-686. [8] 李瑞珍,张月荣,曾家伟,等.网织红细胞系列参数与不同类型贫血患儿的临床应用分析[J].华西医学,2017,32(7):1033-1036. [9] 李绵绵,李芳,余玲玲,等.新型网织红细胞参数在贫血早期诊断中的价值[J].中国卫生检验杂志,2019,29(11):1289-1291. |
[1] |
. [J]. journal1, 2022, 42(6): 74-75. |
[2] |
. [J]. journal1, 2021, 41(4): 57-58. |
[3] |
. [J]. journal1, 2021, 41(1): 97-98. |
|
|
|
|